Bin Zhao

9PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Occupational epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 06, 2025
Drug-associated pancreatic cancer: insights from real-world pharmacovigilance and network pharmacology.

Hao Xie, Qiang Xu, Bin Zhao

|Jun 01, 2022
Does eltrombopag lead to thrombotic events? A pharmacovigilance study of the FDA adverse event reporting system.

Jing-Jing Jiang, Bin Zhao, Ji Li

|May 17, 2022
Acute kidney injury following SGLT2 inhibitors among diabetic patients: a pharmacovigilance study.

Gang Chen, Xiaolin Li, Quexuan Cui

|Jan 21, 2021
Guillain-Barré syndrome in patients treated with immune checkpoint inhibitors.

Qianqian Fan, Yang Hu, Xiang Wang

|Dec 16, 2020
Do sodium-glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real-world study.

Bin Zhao, Juan Shen, Jun Zhao

Pageof 2